Hypothesis

Emodin, by inhibiting EGFR/MAPK pathways in microglia, shifts the threshold for activity‑dependent neuronal eviction in the aged brain, allowing metabolically expensive but weakly connected neurons to survive longer.

Mechanistic Rationale

Microglia use EGFR‑ERK signaling to upregulate complement components C1q and C3, tagging synapses and neurons for removal【1†L1-L3】. In aging, chronic EGFR activation may lower the threshold for evicting inefficient neurons, akin to developmental pruning. Emodin’s EGFR inhibition reduces MAPK phosphorylation【2†L1-L2】, which we predict decreases microglial complement expression and phagocytic activity. Concurrently, emodin’s indirect effect on CDK2‑ERK crosstalk【3†L1-L3】 may further dampen proliferative signaling that sustains the microglial state primed for elimination.

Predictions & Experimental Design

1. In vivo: Aged mice (24 mo) receive chronic emodin (30 mg/kg/day) or vehicle for 8 weeks. We expect:
   • Reduced p‑ERK and p‑EGFR levels in Iba1⁺ microglia【4†L1-L2】.
   • Lower cortical and hippocampal C1q/C3 immunoreactivity.
   • Increased survival of NeuN⁺ neurons that show high mitochondrial activity (e.g., TOMM20⁺) but low synaptic input (measured by vGLUT1 puncta density).
2. Ex vivo: Acute hippocampal slices treated with emodin will display decreased microglial phagocytosis of synaptosomes labeled with pHrodo.
3. Behavioral: Despite preserved 'inefficient' neurons, treated mice should not show worsened spatial memory in the Morris water maze, testing the hypothesis that neuronal eviction is not required for cognitive maintenance.

Potential Implications

If emodin rescues neurons deemed inefficient by microglial quality control, it challenges the view that age‑related neuronal loss is purely protective. Instead, it suggests that senotherapeutics can uncouple metabolic cost from survival, offering a lever to modulate brain remodeling without globally suppressing inflammation.

References

1 – EGFR/MAPK inhibition attenuates M1 macrophage polarization. 2 – Emodin induces apoptosis via caspase‑3/Bax in cancer cells. 3 – CDK2 inhibition promotes neuronal differentiation by suppressing MYC/E2F. 4 – EGFR/ERK modulation creates crosstalk with CDK2‑ERK regulation. 5 – EGFR inhibition reduces neuroinflammation and Aβ plaque in Alzheimer models.